Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SPRINT.STthis companySprint Bioscience AB	SEK 4.02	1.48×	1.14×	0.81×	0.1×	-585.4%	58.2%	58.2%	54.9%	77.0%	81.7%	61.3%	0×	-1.29×	15.68×	7.6×	0.0%	4	16.98	3	B+
ACOU.STAcouSort AB	SEK 3.12	-4.42×	3.27×	7.79×	-3.29×	-1703.2%	-211.6%	-211.6%	-177.3%	-74.6%	-89.0%	-32.4%	0×	0.44×	-10.85×	8.19×	0.0%	2	-4.93	1	D+
ACTI.STActive Biotech AB	SEK 3.44	-166.06×	111.47×	0×	-170.4×	-98.9%	0.0%	0.0%	0.0%	-67.1%	-65.6%	-0.5%	0.03×	1.76×	0×	4.66×	0.0%	3	4.44	2	C+
ATORX.STAlligator Bioscience AB (publ)	SEK 0.01	-0.18×	1.35×	18.04×	0.08×	6004.4%	-10665.2%	-23780.5%	-9990.3%	-748.7%	-244.4%	-1697.7%	6.29×	0.16×	-2.76×	0.88×	0.0%	1	-24.71	2	B-
IDLDX.STIDL Diagnostics AB (publ)	SEK 0.32	-6.7×	0.55×	1.53×	-7.18×	-1307.2%	52.2%	-20.2%	-22.9%	-8.2%	-6.6%	-11.3%	0.09×	2.89×	-24.09×	3.21×	0.0%	3	0.24	4	A
ONCOZ.STOncoZenge AB (publ)	SEK 3.20	-5.16×	-139.7×	30.78×	-5.41×	-72.6%	-181.7%	-595.7%	-598.3%	2715.5%	-229.6%	-15.9%	-12.78×	-0.24×	-93.91×	1.01×	0.0%	2	-18.16	2	C
Peer median	—	-5.16×	1.35×	7.79×	-5.41×	-98.9%	-181.7%	-211.6%	-177.3%	-67.1%	-89.0%	-15.9%	0.03×	0.44×	-10.85×	3.21×	0.0%	2	-4.93	2	—